Solventum Corporation (SOLV)
NYSE: SOLV
· Real-Time Price · USD
71.72
-1.48 (-2.02%)
At close: Aug 15, 2025, 3:03 PM
Solventum Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Revenue | 8.39B | 8.31B | 8.25B | 8.27B | 8.27B | 8.23B | 8.26B | 8.17B | 8.1B | 8.12B | 8.13B | 6.13B | 4.12B | 2.06B |
Cost of Revenue | 3.81B | 3.77B | 3.66B | 3.69B | 3.67B | 3.61B | 3.64B | 3.56B | 3.52B | 3.48B | 3.44B | 2.54B | 1.68B | 839.5M |
Gross Profit | 4.57B | 4.54B | 4.59B | 4.59B | 4.63B | 4.66B | 4.65B | 4.64B | 4.58B | 4.64B | 4.7B | 3.59B | 2.44B | 1.22B |
Operating Income | 777M | 807M | 1.04B | 1.25B | 1.48B | 1.65B | 1.64B | 1.67B | 1.59B | 1.61B | 1.69B | 1.31B | 885M | 442.5M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 321M | 314M | 605M | 771M | 1.1B | 1.42B | 1.46B | 1.66B | 1.58B | 1.61B | 1.69B | 1.31B | 886M | 443M |
Net Income | 380M | 379M | 479M | 521M | 859M | 1.09B | 1.15B | 1.38B | 1.26B | 1.29B | 1.34B | 1.04B | 701M | 350.5M |
Selling & General & Admin | 3.03B | 2.96B | 2.78B | 2.57B | 2.45B | 2.31B | 2.27B | 2.24B | 2.2B | 2.22B | 2.24B | 1.7B | 1.15B | 577M |
Research & Development | 770M | 773M | 775M | 766M | 756M | 758M | 757M | 753M | 757M | 762M | 767M | 581M | 398M | 199M |
Other Expenses | n/a | n/a | n/a | n/a | -55M | -342M | -344M | -344M | -289M | -2M | n/a | n/a | n/a | n/a |
Operating Expenses | 3.8B | 3.73B | 3.56B | 3.34B | 3.15B | 3.04B | 3.02B | 2.98B | 3B | 3B | 3B | 2.28B | 1.55B | 775.5M |
Interest Expense | 421M | 432M | 367M | 260M | 153M | 39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.61B | 7.5B | 7.22B | 7.02B | 6.79B | 6.61B | 6.63B | 6.5B | 6.52B | 6.48B | 6.44B | 4.82B | 3.23B | 1.61B |
Income Tax Expense | -58M | -64M | 127M | 250M | 245M | 330M | 308M | 278M | 326M | 326.5M | 349M | 273M | 185M | 92.5M |
Shares Outstanding (Basic) | 174.1M | 173.7M | 173.4M | 173.4M | 173.2M | 172.7M | 172.47M | 172.47M | 172.47M | 172.47M | 172.47M | 172.47M | 172.47M | 172.47M |
Shares Outstanding (Diluted) | 175.2M | 174.8M | 174.5M | 173.9M | 173.5M | 172.7M | 172.47M | 172.47M | 172.47M | 172.47M | 172.47M | 172.47M | 172.47M | 172.47M |
EPS (Basic) | 2.19 | 2.18 | 2.76 | 4.15 | 6.12 | 7.39 | 7.80 | 8.01 | 7.28 | 7.53 | 7.78 | 6.00 | 4.06 | 2.03 |
EPS (Diluted) | 2.17 | 2.17 | 2.76 | 4.15 | 6.12 | 7.39 | 7.80 | 8.01 | 7.28 | 7.53 | 7.78 | 6.00 | 4.06 | 2.03 |
EBITDA | 1.28B | 1.29B | 1.53B | 1.75B | 1.88B | 2.08B | 2.09B | 2.13B | 2.16B | 2.19B | 2.27B | 1.74B | 1.17B | 585M |
EBIT | 742M | 746M | 972M | 1.2B | 1.43B | 1.64B | 1.63B | 1.5B | 1.43B | 1.45B | 1.53B | 1.31B | 885M | 442.5M |
Depreciation & Amortization | 534M | 545M | 555M | 544M | 555M | 555M | 561M | 573M | 571M | 580.5M | 578M | 427M | 285M | 142.5M |